S. Mattioni, K. Stojanovic, R. Girot, F. Lionnet, and . La-drépanocytose-en-france, La dr??panocytose en France, Revue Francophone des Laboratoires, vol.2016, issue.481, pp.61-67, 2016.
DOI : 10.1016/S1773-035X(16)30129-0

O. Platt, D. Brambilla, W. Rosse, P. Milner, O. Castro et al., Mortality In Sickle Cell Disease -- Life Expectancy and Risk Factors for Early Death, New England Journal of Medicine, vol.330, issue.23, pp.1639-1683, 1994.
DOI : 10.1056/NEJM199406093302303

G. Serjeant, D. Higgs, and I. Hambleton, Elderly Survivors with Homozygous Sickle Cell Disease, New England Journal of Medicine, vol.356, issue.6, pp.642-645, 2007.
DOI : 10.1056/NEJMc066547

A. Habibi, J. Arlet, K. Stankovic, J. Gellen-dautremer, J. Ribeil et al., Recommandations françaises de prise en charge de la drépanocytose de l'adulte : actualisation 2015. La Revue de Médecine Interne, pp.5-8, 2015.
DOI : 10.1016/s0248-8663(15)60002-9

M. Thein, N. Igbineweka, and S. Thein, Sickle cell disease in the older adult, Pathology, vol.49, issue.1, pp.1-9, 2017.
DOI : 10.1016/j.pathol.2016.10.002

P. Bartolucci, Hemoglobin disorders: an advantage against malaria, but the risk of severe disease], Rev Prat. oct, vol.64, issue.8, pp.1110-1111, 2014.

J. Lindenau, S. Wagner, S. Castro, . De, and M. Hutz, The effects of old and recent migration waves in the distribution of HBB*S globin gene haplotypes, Genetics and Molecular Biology, vol.86, issue.4, pp.515-538, 2016.
DOI : 10.1002/(SICI)1096-8652(200002)63:2<79::AID-AJH4>3.0.CO;2-D

R. Cally, L. Benarous, M. Ete, M. Patient, A. Martin et al., Causes de d??c??s chez les patients dr??panocytaires??: ??tude monocentrique de la cohorte marseillaise, La Revue de M??decine Interne, vol.36, issue.2, p.133, 2015.
DOI : 10.1016/j.revmed.2015.10.076

E. Gomes, K. Castetbon, and V. Goulet, Mortalité liée à la drépanocytose en France: Âge de décès et causes associées (1979-2010) Bulletin épidémiologique hebdomadaire, pp.142-50, 2015.

H. Elmariah, M. Garrett, D. Castro, L. Jonassaint, J. Ataga et al., Factors associated with survival in a contemporary adult sickle cell disease cohort, American Journal of Hematology, vol.361, issue.930
DOI : 10.1056/NEJMoa0904971

K. Gardner, A. Douiri, E. Drasar, M. Allman, A. Mwirigi et al., Survival in adults with sickle cell disease in a high-income setting, Blood, vol.128, issue.10, pp.1436-1444, 2016.
DOI : 10.1182/blood-2016-05-716910

S. Ballas, E. Pulte, C. Lobo, and G. Riddick-burden, Case series of octogenarians with sickle cell disease, Blood, vol.128, issue.19, 2016.
DOI : 10.1182/blood-2016-05-715946

V. Perronne, M. Roberts-harewood, D. Bachir, F. Roudot-thoraval, J. Delord et al., Patterns of mortality in sickle cell disease in adults in France and England, The Hematology Journal, vol.3, issue.1, pp.56-60, 2002.
DOI : 10.1038/sj.thj.6200147

F. Pirenne, Évolution des causes de mortalité chez les drépanocytaires adultes, La Revue de Médecine Interne. juin, vol.36, issue.1, pp.41-43, 2015.

J. Giboyau, S. Merle, and J. Rosine, Drépanocytose en Martinique. OSM Flash n° 24-25, janvier et mars, 2000.

H. Conseil-de-la-santé-publique, 2016 mars [cité 29 mars 2017, Disponible sur

S. Merle and V. Gonzalez, Impact économique et social de la drépanocytose chez les patients du CID de Martinique Observatoire de la santé de la Martinique, 2009.

F. Lionnet, K. Stankovic, and R. Girot, Dr??panocytose de l'adulte, EMC - H??matologie, vol.4, issue.2, pp.1-19, 2009.
DOI : 10.1016/S1155-1984(09)49949-7

M. Nouraie, N. Reading, A. Campbell, C. Minniti, S. Rana et al., Association of G6PD with lower haemoglobin concentration but not increased haemolysis in patients with sickle cell anaemia, Br J Haematol. juill, vol.150, issue.2, pp.218-243, 2010.

F. Lionnet, N. Hammoudi, K. Stojanovic, V. Avellino, G. Grateau et al., Hemoglobin sickle cell disease complications: a clinical study of 179 cases, Haematologica, vol.97, issue.8, pp.1136-1177, 2012.
DOI : 10.3324/haematol.2011.055202

J. Gellen-dautremer, V. Brousse, and J. Arlet, Management of acute complications in sickle cell disease ], Rev Prat. oct, vol.64, issue.8, pp.1114-1123, 2014.

A. Wallois, E. Vian, G. Loko, and P. Blanchet, ??valuation de la sexualit?? chez les patients afro-carib??ens dr??panocytaires homozygotes SS suivis en Martinique, Progr??s en Urologie, vol.22, issue.5, pp.301-307, 2012.
DOI : 10.1016/j.purol.2011.09.015

J. Hord, B. Windsor, M. Koehler, J. Blatt, J. Janosky et al., Diminished Antibody Response to Hepatitis B Immunization in Children With Sickle Cell Disease, Journal of Pediatric Hematology/Oncology, vol.24, issue.7, pp.548-557, 2002.
DOI : 10.1097/00043426-200210000-00010

J. Arlet, C. Comarmond, D. Vincent, A. Habibi, L. Affo et al., Infection par le virus de l???h??patite C et dr??panocytose??: pr??valence, caract??ristiques et manifestations extrah??patiques, ??tude multicentrique fran??aise, La Revue de M??decine Interne, vol.37, issue.1, pp.62-65, 2016.
DOI : 10.1016/j.revmed.2016.04.279

L. Turdu-chicot, C. Foucan, L. , E. , and M. , S??ropr??valence virale, transfusion et allo-immunisation chez des adultes dr??panocytaires guadeloup??ens, Transfusion Clinique et Biologique, vol.9, issue.2, pp.115-135, 2002.
DOI : 10.1016/S1246-7820(02)00234-3

A. Gessain and R. Mahieux, Tropical spastic paraparesis and HTLV-1 associated myelopathy: Clinical, epidemiological, virological and therapeutic aspects, Revue Neurologique, vol.168, issue.3, pp.257-69, 2012.
DOI : 10.1016/j.neurol.2011.12.006

L. Willems, H. Hasegawa, R. Accolla, C. Bangham, A. Bazarbachi et al., Reducing the global burden of HTLV-1 infection: An agenda for research and action, Antiviral Research, vol.137, pp.41-49, 2017.
DOI : 10.1016/j.antiviral.2016.10.015

A. Gessain, L. Gazzolo, M. Yoyo, L. Fortier, M. Robert-guroff et al., Sickle-cellanaemia patients from Martinique have an increased prevalence of HLTV-i antibodies

C. Rieux, D. Meyer, E. Boudjedir, and K. , Les h??molyses retard??es post-transfusionnelles chez les patients dr??panocytaires??: un nouveau d??fi pour le r??seau d???h??movigilance, Transfusion Clinique et Biologique, vol.22, issue.1, pp.37-41, 2015.
DOI : 10.1016/j.tracli.2014.09.004

P. Richard, O. Amar, and K. , Du donneur au receveur??: particularit??s de la cha??ne transfusionnelle dans les DOM, Transfusion Clinique et Biologique, vol.20, issue.2, pp.59-67, 2013.
DOI : 10.1016/j.tracli.2013.02.027

K. Castetbon, L. Ramalli, A. Vaidie, C. Yacou, S. Merle et al., Consommations alimentaires et biomarqueurs nutritionnels chez les adultes de 16 ans et plus en Guadeloupe et Martinique. Enquête Kannari 2013-2014, Bull Epidémiol Hebd, issue.4, pp.52-62, 2016.

I. Shatat, S. Jakson, A. Blue, M. Johnson, J. Orak et al., Masked hypertension is prevalent in children with sickle cell disease: a Midwest Pediatric Nephrology Consortium study, Pediatric Nephrology, vol.31, issue.1, pp.115-135, 2013.
DOI : 10.2337/dc07-0824

G. Damanhouri, J. Jarullah, S. Marouf, S. Hindawi, G. Mushtaq et al., Clinical biomarkers in sickle cell disease, Saudi Journal of Biological Sciences, vol.22, issue.1, pp.24-31, 2015.
DOI : 10.1016/j.sjbs.2014.09.005

S. Zorca, L. Freeman, M. Hildesheim, D. Allen, A. Remaley et al., Lipid levels in sickle-cell disease associated with haemolytic severity, vascular dysfunction and pulmonary hypertension, British Journal of Haematology, vol.113, issue.3, pp.436-481, 2010.
DOI : 10.1093/tropej/41.4.202

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3212812/pdf

J. Arlet, J. Ribeil, G. Chatellier, D. Eladari, D. Seigneux et al., Determination of the best method to estimate glomerular filtration rate from serum creatinine in adult patients with sickle cell disease: a prospective observational cohort study, BMC Nephrology, vol.167, issue.1, p.83, 2012.
DOI : 10.1001/archinte.167.7.701

URL : https://hal.archives-ouvertes.fr/inserm-00739156

P. Bartolucci and F. Lionnet, Chronic complications of sickle cell disease], Rev Prat. oct, vol.64, issue.8, pp.1120-1126, 2014.

G. Agboton, G. Loko, A. Gbaguidi, N. Kontcho, F. Digny et al., Pr??valence des atteintes r??nales chez les dr??panocytaires SS, N??phrologie & Th??rapeutique, vol.9, issue.5, p.333, 2013.
DOI : 10.1016/j.nephro.2013.07.043

P. Drawz, S. Ayyappan, M. Nouraie, S. Saraf, V. Gordeuk et al., Kidney Disease among Patients with Sickle Cell Disease, Hemoglobin SS and SC, Clinical Journal of the American Society of Nephrology, vol.11, issue.2, pp.207-222, 2016.
DOI : 10.2215/CJN.03940415

URL : http://cjasn.asnjournals.org/content/11/2/207.full.pdf

F. Parent, D. Bachir, J. Inamo, F. Lionnet, F. Driss et al., A Hemodynamic Study of Pulmonary Hypertension in Sickle Cell Disease, New England Journal of Medicine, vol.365, issue.1, pp.44-53, 2011.
DOI : 10.1056/NEJMoa1005565

URL : https://hal.archives-ouvertes.fr/inserm-00609555

M. Bappé, P. Girot, and R. , Osteo-articular complications of sickle-cell-anemia in adult

R. Crawford and C. Jonassaint, Adults with sickle cell disease may perform cognitive tests as well as controls when processing speed is taken into account: a preliminary case-control study, Journal of Advanced Nursing, vol.303, issue.18, pp.1409-1425, 2016.
DOI : 10.1001/jama.2010.562

. Mesvaccins, net -Mon carnet de vaccination électronique, pour être mieux vacciné, sans défaut ni excès

D. Bachir and E. Foïs, Éducation thérapeutique : à intégrer dans le plan de soins. Le Concours médical, avril, vol.138, issue.4, pp.299-300, 2016.

J. Arlet, Prise en charge de l'adulte drépanocytaire, Rev Prat. nov, vol.949, issue.29, pp.715-722, 2015.

L. Ministère-de, . Santé, and . Des-sports, Plan santé outre-mer Juillet Disponible sur : http://socialsante .gouv.fr/IMG/pdf/Plan_sante_outre-mer-2.pdf [57] Présentation de la stratégie de santé pour les outre-mer : intervention de Marisol TOURAINE, 2009.